Spinout Active LTD

Company profile

Topmd Precision Medicine Ltd

TopMD

Topmd Precision Medicine Ltd is a UK company with status active founded in 2019 based in South East England.

CRN
12168015
Founded
2019
Age
6

Overview

Browse spinouts
Legal name
TOPMD PRECISION MEDICINE LTD
Region
South East England
Registered address
64 LABURNUM CRESCENT
SOUTHAMPTON
UNITED KINGDOM
SO45 3PN
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 May
2027

Accounts due

Accounts Due

Next accounts due date

03 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Aug
2025

Accounts filed

Accounts

Last accounts made up date

20 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Nov
2024

Accounts With Accounts Type Total Exemption Full

Accounts Awaiting analysis

AA | Transaction MzQ0NDc4NTE1NmFkaXF6a2N4

Published 25 Nov 2024 02:38

01 Sep
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzNDEwNDUzMWFkaXF6a2N4

Published 01 Sep 2024 22:27

21 Aug
2019

Incorporated

Inception

Company registered at Companies House

Spinout profile

1 entry

Company description

A company created by a member of the JTD team to exploit topological methods in medical diagnostics.

Project impact

New diagnostic software and methodology.

TOPMD PRECISION MEDICINE LTD
2019

Public funding

2 awards
First funded
2021
Funded years
2021
Age at first award
1 years

Projects

2021 CR&D Bilateral Lead participant

Diagnostic biomarkers of gut microbiome-associated phenotypes predictive of healthy ageing

1 May 2021 to 30 Apr 2023

Awarded
£454,734
Total cost £649,620

Different bacterial populations of gut are associated with longevity and healthy ageing and specific bacteria have been identified which cause immune responses. This project will define combined microbiome and human gene expression biomarker signatures diagnostic of healthy ageing gut phenotypes and associated inflammatory bowel disease (IBD) and/or neuro...

2021 Study Lead participant

ICURe TopMD Pathway Biomarker Catalogue

1 Feb 2021 to 31 Mar 2022

Awarded
£205,604
Total cost £293,720

In this project, we are developing a catalogue, across diseases and treatments, of new, more powerful and informative biomarkers for use as companion diagnostics to predict treatment response in individual patients and for improving the efficiency of the development and testing of medicines. Our AI-enhanced technology, TopMD, was developed at the Universi...

Product types

CR&D Bilateral Study